Advertisement

Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009

Published:April 11, 2013DOI:https://doi.org/10.1016/j.ajog.2013.04.007

      Objective

      To assess adverse fetal outcomes and short-term prognoses of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009 in Japan.

      Study Design

      Case series study. We asked the 2611 obstetric facilities in Japan that are members of the Japan Society of Obstetrics and Gynecology to participate, and data were provided from 157 facilities. We evaluated the numbers of pregnancy complications and neonatal abnormalities.

      Results

      We evaluated 624 infants born to 619 women given oseltamivir and 50 infants born to 50 women given zanamivir. Of patients given oseltamivir before gestational week 22, 3 experienced miscarriage and 1 experienced induced abortion. The overall rate of congenital malformations was 2.1% (14/670). In infants exposed during the first trimester, the rate of malformations was 1.3% (2/156) with oseltamivir and 0.0% (0/15) with zanamivir, although in infants exposed during the second and third trimesters, this rate was 2.6% (12/464) with oseltamivir and 0.0% (0/35) with zanamivir. Increased rates of miscarriage in women given antiviral drugs before gestational week 22 (0.9% [3/322]), preterm delivery in women given antiviral drugs before gestational week 37 (5.5% [33/600]), stillbirth (0% [0/670]), neonatal death (0.15% [1/670]), birthweight <2500 g (8.7% [58/670]), small-for-gestational-age infants (8.4% [56/670]), necrotizing enterocolitis (0.0%), intraventricular hemorrhage (0.0%), seizures (0.15% [1/670]), and other transient abnormalities in the neonatal period (4.3% [29/670]) were not observed in those exposed to antiviral drugs before the corresponding episodes or complications.

      Conclusion

      Short-term prognoses of infants exposed to oseltamivir or zanamivir in utero were not adversely affected.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jamieson D.J.
        • Honein M.A.
        • Rasmussen S.A.
        • et al.
        H1N1 2009 influenza virus infection during pregnancy in the USA.
        Lancet. 2009; 374: 451-458
      1. World Health Organization recommended use of antivirals Pandemic (H1N1) 2009 briefing note 8. Aug 21, 2009.

      2. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. CDC Sept. 8, 2009. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed Dec. 7, 2009.

        • Yamada T.
        • Yamada T.
        • Saito T.
        • Sengoku K.
        • Minakami H.
        No maternal mortality from pandemic (H1N1) 2009 occurred in Japan.
        BMJ. 2010; (Aug 6. Available at:) (Accessed Sept. 29, 2011)
        • Nakai A.
        • Minakami H.
        • Unno N.
        • et al.
        Characteristics of pregnant Japanese women who required hospitalization for treatment of pandemic (H1N1) 2009—low mortality rate may be due to early antiviral use.
        J Infect. 2011; 62: 232-233
        • Yamada T.
        • Yamada T.
        • Morikawa M.
        • et al.
        Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido.
        J Obstet Gynaecol Res. 2012; 38: 130-136
        • Mosby L.G.
        • Rasmussen S.A.
        • Jamieson D.J.
        2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature.
        Am J Obstet Gynecol. 2011; 205: 10-18
        • Liu S.L.
        • Wang J.
        • Yang X.H.
        • et al.
        Pandemic influenza A(H1N1) 2009 virus in pregnancy.
        Rev Med Virol. 2013; 23: 3-14
        • Siston A.M.
        • Rasmussen S.A.
        • Honein M.A.
        • et al.
        Pandemic 2009 Influenza A(H1N1) virus illness among pregnant women in the United States.
        JAMA. 2010; 303: 1517-1525
        • Pasternak B.
        • Svanström H.
        • Mølgaard-Nielsen D.
        • et al.
        Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.
        BMJ. 2012; 344: e2794
        • Pasternak B.
        • Svanström H.
        • Mølgaard-Nielsen D.
        • et al.
        Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
        JAMA. 2012; 308: 165-174
        • Tanaka T.
        • Nakajima K.
        • Murashima A.
        • Garcia-Bournissen F.
        • Koren G.
        • Ito S.
        Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
        CMAJ. 2009; 181: 55-58
        • Greer L.G.
        • Sheffield J.S.
        • Rogers V.L.
        • Roberts S.W.
        • McIntire D.D.
        • Wendel Jr., G.D.
        Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
        Obstet Gynecol. 2010; 115: 711-716
        • Svensson T.
        • Granath F.
        • Stephansson O.
        • Kieler H.
        Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
        Pharmacoepidemiol Drug Saf. 2011; 20: 1030-1034
        • Donner B.
        • Niranjan V.
        • Hoffmann G.
        Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.
        Drug Saf. 2010; 33: 631-642
        • Ogawa Y.
        • Iwamura T.
        • Kuriya N.
        • et al.
        Birth size standards by gestational age for Japanese neonates.
        Acta Neonat Jap. 1998; 34 (in Japanese): 624-632
        • Nybo Andersen A.M.
        • Wohlfahrt J.
        • Christens P.
        • Olsen J.
        • Melbye M.
        Maternal age and fetal loss: population based register linkage study.
        BMJ. 2000; 320: 1708-1712
      3. The report of the study of the Ministry and Health and Welfare in 827 cases in Japan 1991-1993 (in Japanese).

      4. Maternal and child health statistics of Japan. Tokyo, Japan: Edited by Mother's and Children's Health and Welfare Association, March 2010.

        • Jaw T.-S.
        • Jong Y.-J.
        • Sheu R.-S.
        • Liu G.-C.
        • Chou M.-S.
        • Yang R.-C.
        Etiology, timing of insult, and neuropathology of cerebral palsy evaluated with magneteic resonance imaging.
        J Formos Med Assoc. 1998; 97: 239-246
        • Kuban K.C.K.
        • Leviton A.
        Cerebral palsy.
        N Engl J Med. 1994; 330: 188-195
        • Matsuda Y.
        • Hayashi K.
        • Shiozaki A.
        • Kawamichi Y.
        • Sato S.
        • Saito S.
        Comparison of risk factors for placental abruption and placenta previa: case–cohort study.
        J Obstet Gynaecol Res. 2011; 37: 538-556
        • Czeizel A.E.
        • Dudas I.
        Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
        N Engl J Med. 1992; 327: 1832-1835
        • Czeizel A.E.
        Prevention of congenital abnormalities by periconceptional multivitamin supplementation.
        BMJ. 1993; 306: 1645-1648
        • Pietz J.
        • Achanti B.
        • Lilien L.
        • Stepka E.C.
        • Mehta S.K.
        Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience.
        Pediatrics. 2007; 119: e164-e170
      5. European Medical Agency (EMEA). EMEA updates on A/H1N1 influenza virus. Update on 31 July 2009 [online] Available at: http://www.ema.europa.eu/humandocs/PDFs/EPAR/tamiflu/28766209en.pdf. Accessed June 1, 2010.

        • Jackson R.J.
        • Cooper K.L.
        • Tappenden P.
        • et al.
        Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
        J Infect. 2011; 62: 14-25